Motus GI to go public with $25M IPO — 3 insights

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Here's what you should know:

1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.

2. Motus does not yet have a reimbursement code for the Pure-Vu system, and thus needs the public offering to raises funds for further clinical trials.

3. Motus will trade under the symbol MOTS.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast